Uma N. Sundram, MD, PhD

Publication Details

  • Diagnostic utility of fli-1 and d2-40 in distinguishing atypical fibroxanthoma from angiosarcoma. American Journal of dermatopathology Cuda, J., Mirzamani, N., Kantipudi, R., Robbins, J., Welsch, M. J., Sundram, U. N. 2013; 35 (3): 316-318

    Abstract:

    Although in most cases one can easily distinguish between atypical fibroxanthomas and angiosarcomas, hemorrhagic atypical fibroxanthomas can pose a diagnostic problem. In rare cases, the large atypical cells of atypical fibroxanthoma can stain with CD31, leading to the erroneous diagnosis of angiosarcoma. We elected to further study this conundrum with 2 additional markers of lymphatic and vascular elements, namely D2-40 (podoplanin) and Fli-1, respectively. We studied 26 cases of atypical fibroxanthoma and 20 cases of angiosarcoma with Fli-1 and D2-40. We found that both Fli-1 and D2-40 stained a majority of cases of angiosarcoma (16/20 and 12/20, respectively), although only staining a minority of cases of atypical fibroxanthoma (8/26 for both). In addition, D2-40 staining of atypical fibroxanthoma was usually weak when positive, whereas Fli-1 staining of angiosarcomas was mostly strong and nuclear. Thus, both D2-40 and Fli-1 seem to be useful in distinguishing between atypical fibroxanthomas and angiosarcomas.

    View details for DOI 10.1097/DAD.0b013e318266b197

    View details for PubMedID 23518636

Stanford Medicine Resources:

Footer Links: